We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

LICN:NASDAQLichen International Limited Analysis

Data as of 2026-06-11 - not real-time

$2.62

Latest Price

8/10Risk

Risk Level: High

Executive Summary

Lichen International Limited trades at $2.62, modestly above its 20‑day SMA of $2.34 but well below the 50‑day ($4.15) and 200‑day ($3.78) averages, indicating a neutral price trend. The RSI sits at 47, suggesting neither overbought nor oversold conditions, while the MACD histogram is positive, giving a brief bullish signal despite a negative MACD line. Volatility is extreme at roughly 398% over the past 30 days, and the stock has endured a historic max drawdown of about -90%, underscoring severe price swings. Fundamentally, revenue plunged 56% year‑over‑year to $24.5 M and both operating and net margins are deeply negative (‑89% and ‑90% respectively), with EBITDA and cash flow also in the red. The balance sheet shows $26.9 M of cash versus only $0.55 M of debt, yielding a low debt‑to‑equity ratio but the company is burning cash at a high rate. Valuation metrics reflect a price‑to‑book of 0.61, hinting at potential asset‑value upside, yet the lack of earnings renders PE ratios meaningless. No dividend is paid, making dividend sustainability a non‑issue. The business operates in China’s specialty business‑services sector, exposing it to regulatory and geopolitical headwinds. Overall, the stock’s technical picture is mixed, but the overwhelming negative earnings trajectory and extreme volatility dominate the outlook.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 7/10

Key Factors

  • Negative earnings and large cash burn
  • Revenue decline of over 50% YoY
  • Extreme price volatility and recent max drawdown

Medium Term

1–3 years
Neutral
Model confidence: 5/10

Key Factors

  • Low price‑to‑book suggests asset value cushion
  • Strong cash position relative to minimal debt
  • Uncertainty around turnaround of operating performance

Long Term

> 3 years
Positive
Model confidence: 4/10

Key Factors

  • Potential upside if the company restructures and restores profitability
  • Undervalued balance‑sheet metrics provide margin of safety
  • Long‑term growth of China’s service sector could benefit the business

Key Metrics & Analysis

Financial Health

Revenue Growth-56.10%
Profit Margin-89.58%
ROE-29.82%
ROA-11.59%
Debt/Equity0.79
P/B Ratio0.6
Op. Cash Flow$-17849000
Free Cash Flow$-5233750
Industry P/E29.9

Technical Analysis

TrendNeutral
RSI47.5
Support$0.75
Resistance$9.08
MA 20$2.34
MA 50$4.15
MA 200$3.78
MACDBullish
VolumeDecreasing
Fear & Greed Index83.5

Valuation

GradeUndervalued
TypeValue

Risk Assessment

Beta1.17
Volatility398.43%
Sector RiskMedium
Reg. RiskHigh
Geo RiskHigh
Currency RiskMedium
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.